MEMO-Medical Marijuana and Opioids Study
CompletedNCT03268551
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study will examine how medical cannabis use affects opioid analgesic use over time, with particular attention to THC/CBD content, HIV outcomes, and severe adverse events.
Study details
- Official title
- Does Medical Cannabis Reduce Opioid Analgesics in HIV+ and HIV- Adults With Pain?
- Conditions
- Opioid Use
- Marijuana
- Chronic Pain
- Hiv/Aids
- Sponsor
- Albert Einstein College of Medicine
- Collaborators
- Fordham University; Columbia University; National Institute on Drug Abuse (NIDA)
- Start date
- 2018-09-04
- Primary completion
- 2023-07-14
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * At least 18 years of age * English or Spanish fluency * New certification for medical cannabis within 90 days * No medical cannabis use in the 6 months prior to certification * Medical cannabis qualifying complication of "chronic or severe pain" * Use of prescribed or illicit opioid analgesics within 30 days Exclusion Criteria: * Inability to provide informed consent * Inability to complete study visits over 18 months * Qualifying conditions for medical cannabis in NY that are likely to cause unique pain syndromes (cancer, epilepsy, multiple sclerosis, spinal cord injury, amyotrophic lateral sclerosis, Parkinson's disease, inflammatory bowel disease, Hungtington's disease) * Terminal illness * Current or prior psychotic disorder
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03268551